Robson M, Tung N, Conte P et al. OlympiAD remaining In general survival and tolerability outcomes: Olaparib versus chemotherapy cure of medical doctor?s decision in individuals with a germline BRCA mutation and HER2-destructive metastatic breast most cancers. AnnBoost irradiation throughout postmastectomy irradiation has no effect on breast cancer-